You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Profile for Cyprus Patent: 1123394


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Cyprus Patent: 1123394

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jan 5, 2035 Cycle NITYR nitisinone
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Cyprus Drug Patent CY1123394

Last updated: July 28, 2025


Introduction

Cyprus Patent CY1123394 exemplifies a strategic intellectual property asset within the pharmaceutical sector, aiming to secure exclusive rights over a novel therapeutic compound or formulation. Analyzing its scope, claims, and the broader patent landscape provides valuable insights for stakeholders including biotech firms, investors, and competitors seeking to navigate innovation, legal rights, and market positioning.


Scope of Patent CY1123394

The scope of Cyprus patent CY1123394 is defined by its claims and descriptive disclosures, establishing the boundaries of legal protection. Patents generally cover specific chemical entities, pharmaceutical compositions, methods of use, or manufacturing processes.

Key Characteristics of Scope:

  • Legal Boundaries: The patent's scope is deliberately confined to the subject matter as claimed in its claims section. Broad claims may offer extensive protection, potentially covering various derivatives or formulations, whereas narrow claims focus on specific compounds or methods.

  • Pharmaceutical Focus: Given its classification, the patent most likely encompasses:

    • A novel active pharmaceutical ingredient (API) or a pharmacologically active compound.
    • A unique formulation or delivery system enhancing bioavailability or stability.
    • Therapeutic methods applicable for specific indications, potentially including combination therapies.
  • Geographical Exploitation: As a Cyprus patent, the rights are enforceable within Cyprus; however, patents within the European Patent Convention (EPC) framework or via the Patent Cooperation Treaty (PCT) can extend protection across multiple jurisdictions.


Claims Analysis

The claims form the core legal element, establishing what the patent applicant regards as the inventive advance. A thorough review involves:

1. Independent Claims:

  • These usually define the broadest scope.
  • Likely encompass the chemical structure of the novel API, specific dosage forms, or unique therapeutic methods.
  • May highlight particular substituents or isomers designed to improve efficacy, reduce side effects, or extend patent life.

2. Dependent Claims:

  • These refine and specify the independent claims.
  • Could include particular salt forms, polymorphs, or stabilizers.
  • May specify manufacturing processes or particular formulations.

3. Claim Language and Scope:

  • Precise language determines scope; broad, functional language can afford wider protection but risks invalidation if overly encompassing.
  • Narrow claims limit the scope but may be easier to defend.

Legal Strategies in Claim Drafting:

  • The patent likely employs a mix of broad and narrow claims to balance protectiveness and validity.
  • For example, claims might cover a generic class of compounds, with narrower claims protecting specific derivatives.

Patent Landscape

Understanding the landscape involves assessing the patent environment surrounding CY1123394, including prior art, competitors’ patents, and potential patent thickets.

1. Prior Art and Novelty:

  • Examination of prior patents, scientific literature, and patent applications in related therapeutic areas determines the novelty.
  • The patent must demonstrate an inventive step over existing treatments and formulations.

2. Related Patents and Similar Technologies:

  • Patents filed in the same therapeutic domain, such as those covering similar chemical scaffolds or delivery systems, could influence freedom to operate.
  • An intersection with existing patents could limit commercialization unless licensing is secured.

3. Patent Families and Filing Strategies:

  • The patent is probably part of a broader patent family, potentially extending protection to Europe via the European Patent Office (EPO) or globally via PCT applications.
  • Strategic patenting considers territorial markets, patent term extensions, and potential exclusivity periods.

4. Competitive Dynamics:

  • The patent landscape analysis must include the positioning of incumbent and emerging players.
  • Assists in identifying white spaces for potential innovation or areas vulnerable to infringement challenges.

5. Legal Status and Maintenance:

  • The patent’s legal status, validity, and any litigations or oppositions are vital for assessing market reliability.
  • Maintenance fees ensure the patent remains enforceable.

Implications of the Patent Landscape

  • A robust patent estate around CY1123394 confers market exclusivity, potentially providing a competitive advantage.
  • Overlapping patents could result in cross-licensing or patent disputes.
  • The strategic patenting in key jurisdictions influences the commercial trajectory and potential revenue streams.

Concluding Remarks

Cyprus patent CY1123394 encapsulates targeted innovation in the pharmaceutical patent domain, with carefully crafted claims likely designed to protect a novel API or formulation. Its scope appears focused on specific chemical or therapeutic embodiments, framed within the broader patent landscape that includes prior art and competing patents. Effective patent protection, combined with strategic portfolio management, positions the patent holder to capitalize on market exclusivity and protect against infringement.


Key Takeaways

  • Scope determination hinges on well-drafted claims balancing breadth and validity.
  • Claims likely cover specific chemical entities, formulations, or methods, establishing enforceability within Cyprus and potentially broader regions via extensions.
  • Patent landscape analysis reveals critical pathways for navigating existing intellectual property and avoiding infringement.
  • Strategic patent filing, including territorial rights and patent family expansion, is integral for maintaining market exclusivity.
  • Regular patent status reviews and legal vigilance safeguard patent rights and support commercialization efforts.

FAQs

1. How does the scope of a patent impact its enforceability?
A broader scope provides extensive protection but may be more challenging to defend against invalidation. Narrow claims are easier to defend but offer limited coverage, emphasizing the importance of claim drafting precision.

2. Can the patent claims cover all formulations of a specific drug?
Not necessarily. Claims are limited to what is explicitly claimed. To cover multiple formulations, multiple claim sets or broader claims are needed, but these risk validity challenges.

3. How does the patent landscape influence drug development strategies?
A detailed landscape guides innovators in identifying patent red zones, potential freedom-to-operate issues, and white spaces for novel developments.

4. Are patents like CY1123394 enforceable internationally?
No, patents are territorial. However, international patent applications via PCT can streamline the process to obtain protections in multiple jurisdictions.

5. What role does patent maintenance play in the value of CY1123394?
Maintenance fees keep the patent in force; lapses can open opportunities for competitors, reducing exclusivity and market control.


References

  1. [1] European Patent Office (EPO) — Guidelines for Examination.
  2. [2] World Intellectual Property Organization (WIPO) — Patent Scope Database.
  3. [3] Patent Docs — Strategies for Pharmaceutical Patent Claim Drafting.
  4. [4] Lipinski’s Rule of Five and its relevance to pharmaceutical patenting.
  5. [5] International Patent Classification (IPC) codes relevant to pharmaceuticals.

Note: Since specific claim texts and detailed legal status for Cyprus patent CY1123394 are not publicly disclosed here, this analysis is based on standard industry practices and the typical scope of pharmaceutical patents, supplemented with hypothetical strategic insights.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.